Close Menu

NEW YORK – A consortium led by investigators at the University of Lille in France has been awarded €2.3 million ($2.7 million) to develop a surface plasmon resonance-based device for detecting SARS-CoV-2 at the point of care. The effort, called "Coronavirus diagnostics using surface plasmon resonance," or CorDial-S, is funded to run for the next 12 months.

The effort is one of 23 research projects selected as part of a new, €128 million EU package to combat COVID-19.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.